(19)
(11) EP 1 326 824 A1

(12)

(43) Date of publication:
16.07.2003 Bulletin 2003/29

(21) Application number: 01972947.4

(22) Date of filing: 21.09.2001
(51) International Patent Classification (IPC)7: C07C 211/30, C07C 217/56, C07D 333/58, C07D 333/54, C07D 333/56, C07D 307/81, A61K 31/135, A61K 31/343, A61K 31/381, A61K 31/445, A61K 31/47, A61K 31/46, A61P 25/28, C07D 307/79, C07D 307/80
(86) International application number:
PCT/US0127/725
(87) International publication number:
WO 0202/8815 (11.04.2002 Gazette 2002/15)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 04.10.2000 GB 0024318

(71) Applicant: ELI LILLY AND COMPANY
Indianapolis, IN 46285 (US)

(72) Inventors:
  • KEENAN, Martine
    Basingstoke,Hampshire RG21 2XA (GB)
  • ROCCO, Vincent, Patrick
    Indianapolis, IN 46250 (US)
  • TAKEUCHI, Kumiko
    Indianapolis, IN 46268 (US)
  • TUPPER, David Edward
    Basingstoke,Hampshire RG21 2XA (GB)
  • VIVIEN, Vincent
    F-67000 Strasbourg (FR)

(74) Representative: Kingsbury, Oliver William 
Eli Lilly and Company Limited,Erl Wood Manor,Sunninghill Road
Windlesham, Surrey GU20 6PH
Windlesham, Surrey GU20 6PH (GB)

   


(54) PHARMACEUTICAL COMPOUNDS